AleAnna, Inc. (ANNA)
NASDAQ: ANNA · Real-Time Price · USD
10.60
+0.89 (9.17%)
At close: Apr 10, 2025, 4:00 PM
10.82
+0.22 (2.08%)
Pre-market: Apr 11, 2025, 5:09 AM EDT
AleAnna Revenue
In the year 2024, AleAnna had annual revenue of $1.42M. AleAnna had revenue of $771.70K in the quarter ending December 31, 2024.
Revenue (ttm)
$1.42M
Revenue Growth
n/a
P/S Ratio
285.80
Revenue / Employee
$202,861
Employees
7
Market Cap
705.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.42M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionANNA News
- 10 days ago - AleAnna, Inc. Reports Fiscal Year 2024 Results - GlobeNewsWire
- 4 weeks ago - AleAnna, Inc. Announces the Near-Term Start of Production at Longanesi Field - GlobeNewsWire
- 2 months ago - AleAnna, Inc. To Celebrates Public Listing With NASDAQ Bell-Ringing Ceremony - GlobeNewsWire
- 4 months ago - AleAnna Announces Signing of Gas Sale Contract with Shell Energy Europe - GlobeNewsWire
- 4 months ago - AleAnna, Inc. Announces Completion of Several Major Milestones for its Renewable Natural Gas (RNG) Business - GlobeNewsWire
- 4 months ago - BRS Resources Announces Update on AleAnna Energy, LLC - Newsfile Corp
- 1 year ago - HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp. - Business Wire
- 2 years ago - HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment - Business Wire